Skip to main content
Premium Trial:

Request an Annual Quote

Lentigen Closes Undisclosed Seed, Series A Financing Round

NEW YORK, Dec. 2 (GenomeWeb News) - Lentigen has secured its seed and series A financing from Greenwich Biotech Ventures, the company said today.


The company said the undisclosed funding will allow it to begin developing lentiviral vectors, which are vehicles that can deliver genes or RNAi into cells. The funding will also add to the company's commercial scale manufacturing capabilities, and increase its infrastructure.


Terms of the financing were not disclosed.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.